|
1
|
Kok J and Dwyer DE: How common was 2009
pandemic influenza A H1N1? Lancet Infect Dis. 11:423–424. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization. Pandemic (H1N1)
- update 112. http://www.who.int/csr/don/2010_08_06/en/indexhtml.
Accessed November 10, 2011
|
|
3
|
Memoli MJ, Morens DM and Taubenberger JK:
Pandemic and seasonal influenza: therapeutic challenges. Drug
Discov Today. 13:590–595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cox MM: Pandemic influenza: overview of
vaccines and antiviral drugs. Yale J Biol Med. 78:321–328.
2005.PubMed/NCBI
|
|
5
|
Podolec P and Kopeć G: Influenza vaccines
for prevention of cardiovascular diseases. Kardiol Pol. 65:612–615.
2007.(In Polish).
|
|
6
|
Lambert LC and Fauci AS: Influenza
vaccines for the future. N Engl J Med. 363:2036–2044. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugrue RJ, Tan BH, Yeo DS and Sutejo R:
Antiviral drugs for the control of pandemic influenza virus. Ann
Acad Med Singapore. 37:518–524. 2008.PubMed/NCBI
|
|
8
|
Moss RB, Davey RT, Steigbigel RT and Fang
F: Targeting pandemic influenza: a primer on influenza antivirals
and drug resistance. J Antimicrob Chemother. 65:1086–1093. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fedson DS: Confronting an influenza
pandemic with inexpensive generic agents: can it be done? Lancet
Infect Dis. 8:571–576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tleyjeh IM, Kashour T, Hakim FA, et al:
Statins for the prevention and treatment of infections: a
systematic review and meta-analysis. Arch Intern Med.
169:1658–1667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou Q and Liao JK: Pleiotropic effects of
statins: basic research and clinical perspectives. Circ J.
74:818–826. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Corsini A, Ferri N and Cortellaro M: Are
pleiotropic effects of statins real? Vasc Health Risk Manag.
3:611–613. 2007.PubMed/NCBI
|
|
13
|
Terblanche M, Smith TS and Adhikari NK:
Statins, bugs and prophylaxis: intriguing possibilities. Crit Care.
10:1682006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tisoncik JR, Korth MJ, Simmons CP, Farrar
J, Martin TR and Katze MG: Into the eye of the cytokine storm.
Microbiol Mol Biol Rev. 76:16–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Montoya CJ, Jaimes F, Higuita EA, et al:
Antiretroviral effect of lovastatin on HIV-1-infected individuals
without highly active antiretroviral therapy (The LIVE study): a
phase-II randomized clinical trial. Trials. 10:412009. View Article : Google Scholar
|
|
16
|
Gower TL and Graham BS: Antiviral activity
of lovastatin against respiratory syncytial virus in vivo and in
vitro. Antimicrob Agents Chemother. 45:1231–1237. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frost FJ, Petersen H, Tollestrup K and
Skipper B: Influenza and COPD mortality protection as pleiotropic,
dose-dependent effects of statins. Chest. 131:1006–1012. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwong JC, Li P and Redelmeier DA:
Influenza morbidity and mortality in elderly patients receiving
statins: a cohort study. PLoS One. 4:e80872009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayden F: Developing new antiviral agents
for influenza treatment: what does the future hold? Clin Infect
Dis. 48(Suppl 1): S3–S13. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nair P and Roguin A: Statins and the acute
coronary syndrome: ‘the early bird catches the worm’. Int J Clin
Pract. 60:716–727. 2006.
|
|
21
|
Ye J, Wang C, Sumpter R Jr, Brown MS,
Goldstein JL and Gale M Jr: Disruption of hepatitis C virus RNA
replication through inhibition of host protein geranylgeranylation.
Proc Nat Acad Sci USA. 100:15865–15870. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
del Real G, Jiménez-Baranda S, Mira E, et
al: Statins inhibit HIV-1 infection by down-regulating Rho
activity. J Exp Med. 200:541–547. 2004.PubMed/NCBI
|
|
23
|
Moncunill G, Negredo E, Bosch L, et al:
Evaluation of the anti-HIV activity of statins. AIDS. 19:1697–1700.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janssen NE, van Lelyveld SF, Hoepelman AI,
Gras L, Groenwold RH and Oosterheert JJ: The effect of statin
therapy on pneumonia in an HIV-infected population in the
Netherlands. J Infect. 67:238–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grau AC and George SM: Improved outcomes
in community-acquired pneumonia with prior statin use. Am J Med.
122:e15author reply e17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chalmers JD, Singanayagam A, Murray MP and
Hill AT: Prior statin use is associated with improved outcomes in
community-acquired pneumonia. Am J Med. 121:1002–1007. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo YF and Hu DY: Statin use and reduced
prevalence of sepsis. Zhonghua Nei Ke Za Zhi. 46:798–800. 2007.(In
Chinese).
|
|
28
|
Almog Y, Shefer A, Novack V, et al: Prior
statin therapy is associated with a decreased rate of severe
sepsis. Circulation. 110:880–885. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Guo Z, Wang G, et al: Evaluation of
the efficacy and safety of a statin/caffeine combination against
H5N1, H3N2 and H1N1 virus infection in BALB/c mice. Eur J Pharm
Sci. 38:215–223. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin Y, Zhang G, Hu Y, et al: Inhibition of
highly pathogenic avian H5N1 influenza virus propagation by RNA
oligonucleotides targeting the PB2 gene in combination with
celecoxib. J Gene Med. 13:243–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hui DS, Lee N and Chan PK: Adjunctive
therapies and immunomodulatory agents in the management of severe
influenza. Antiviral Res. 98:410–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Node K, Fujita M, Kitakaze M, Hori M and
Liao JK: Short-term statin therapy improves cardiac function and
symptoms in patients with idiopathic dilated cardiomyopathy.
Circulation. 108:839–843. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Radigan KA, Urich D, Misharin AV, et al:
The effect of rosuvastatin in a murine model of influenza A
infection. PLoS One. 7:e357882012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Belser JA, Szretter KJ, Katz JM and Tumpey
TM: Simvastatin and oseltamivir combination therapy does not
improve the effectiveness of oseltamivir alone following highly
pathogenic avian H5N1 influenza virus infection in mice. Virology.
439:42–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zarogiannis SG, Noah JW, Jurkuvenaite A,
Steele C, Matalon S and Noah DL: Comparison of ribavirin and
oseltamivir in reducing mortality and lung injury in mice infected
with mouse adapted A/California/04/2009 (H1N1). Life Sci.
90:440–445. 2012. View Article : Google Scholar : PubMed/NCBI
|
